Skip to main content

Part of the book series: Contemporary Endocrinology ((COE,volume 7))

Abstract

The diagnosis and staging of severity of the diabetic neuropathy plays an important role not only for following up patients in a daily clinical practice, but also for the conduction of research that studies the etiopathogenesis of the disease and the development of new therapeutic modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Consensus Statement Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes 1988;37:1000–1004.

    Google Scholar 

  2. Melzack R. The McGill Pain Questionnaire, major properties and scoring methods. Pain 1974;1:277–299.

    Article  Google Scholar 

  3. Masson EA, Hunt L, Gem JM, Boulton AJM. A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy. Pain 1989;38:25–28.

    Article  PubMed  CAS  Google Scholar 

  4. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976;2:175–184.

    Article  PubMed  CAS  Google Scholar 

  5. Boulton AJM, Scarpello JHB, Armstrong WD, Ward JD. The natural history of painful diabetic neuropathy —a 4-year study. Postgrad Med J 1983;59:16–19.

    Google Scholar 

  6. Dyck PJ, Sherman WR, Hallcher LM, Service J, O’Brian PC, Grina LC, Palumbo PJ, Swanson CJ. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590–596.

    Article  PubMed  CAS  Google Scholar 

  7. Dyck PJ, Karnes J, O’Brien PC, Swanson CJ. Neuropathy symptom profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology 1986;36:1300–1308.

    Article  PubMed  CAS  Google Scholar 

  8. Tesfaye S, Stevens L, Stephenson J, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD. The prevalence of diabetic peripheral neuropathy and its relation to glycemic control and potential risk factors: the Eurodiab IDDM complication study. Diabetologia 1996;39:1377–1384.

    Article  PubMed  CAS  Google Scholar 

  9. Veves A, Uccioli L, Manes C, Van Acker K, Komninou H, Philippides P, Katsilambros N, De Leeuw I, Menzinger G, Boulton AJM. Comparisons of risk factors for foot problems in diabetic patients attending teaching hospitals outpatient clinics in four different European states. Diabetic Med 1994;11:709–713.

    Article  PubMed  CAS  Google Scholar 

  10. Veves A, Donaghue VM, Sarnow MR, Giurini JM, Campbell DR, LoGerfo FW. The impact of reversal of hypoxia by revascularization in the peripheral nerve function of diabetic patients. Diabetologia 1996;39:344–348.

    Article  PubMed  CAS  Google Scholar 

  11. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ, O’Brian PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, Service FJ, Rizza RA, Zimmerman BR. The Rochester diabetic neuropathy study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;41:799–807.

    Article  PubMed  CAS  Google Scholar 

  12. Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes 1986;35:192–197.

    Article  PubMed  CAS  Google Scholar 

  13. Feldman EL, Srevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281–1289.

    Article  PubMed  CAS  Google Scholar 

  14. Steiness IB. Vibratory perception in normal subjects. A biothesiometer study. Acta Med Scandloose 1957;158:327–335.

    Article  CAS  Google Scholar 

  15. Bloom S, Till S, Sonksen, Smith S. Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects. Brit Med J 1984;288:1783–1785.

    Article  Google Scholar 

  16. Wiles PG, Pearce SM, Rice PJS, Mitchell JMO. Vibration Perception Threshold: influence of age, height, sex, and smoking and calculation of accurate centile values. Diabetic Med 1991;8:157–161.

    Article  PubMed  CAS  Google Scholar 

  17. Tegner R. The effect of skin temperature on vibratory sensitivity in polyneuropathy. J Neurol Neurosurg Psychiatry 1985;48:176–178.

    Article  PubMed  CAS  Google Scholar 

  18. Valensi P, Attali JR, Gagnat S. Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy. Diabetic Med 1993;10:933–939.

    Article  PubMed  CAS  Google Scholar 

  19. Williams G, Gill JS, Aber V, Mather HM. Variability in vibration perception threshold among sites: a potential source of error in biothesiometry. Brit Med J 1988;286:233–235.

    Article  Google Scholar 

  20. Donaghue VM, Giurini JM, Rosenblum BI, Weissman PN, Veves A. Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. Diabet Res Clin Pract 1995;29:37–42.

    Article  CAS  Google Scholar 

  21. Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic foot ulceration using vibration thresholds: a prospective study. Diabetes Care 1994;17:557–560.

    Article  PubMed  CAS  Google Scholar 

  22. Sosenko JM, Kato M, Soto R, Bild DE. Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care 1990;13:1057–1061.

    Article  PubMed  CAS  Google Scholar 

  23. Birke JA, Sims DS. Plantar sensory threshold in ulcerative foot. Leprosy Rev 1986;57:261–267.

    PubMed  CAS  Google Scholar 

  24. Kumar S, Fernando DJS, Veves A, Knowles EA, Young MJ, Boulton AJM. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991;13:63–68.

    Article  PubMed  CAS  Google Scholar 

  25. Ziegler D, Mayer P, Wiefels K, Gries FA. Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain 1988;34:1–10.

    Article  PubMed  CAS  Google Scholar 

  26. Jamal GA, Weir AI, Hansen S, Ballantyne JP. An improved automated method for the measurement of thermal thresholds. 2. Patients with peripheral neuropathy. J Neurol Neurosurg Psychiatry 1985;48:361–366.

    Article  PubMed  CAS  Google Scholar 

  27. Bertelsmann FW, Heimans JJ, Weber EJM, Van der Veen EA, Schouten JA. Thermal discrimination threshold in normal subjects and in patients with diabetic neuropathy. J Neurol Neurosurg Psychiatry 1985;48:686–690.

    Article  PubMed  CAS  Google Scholar 

  28. Masson EA, Veves A, Fernando D, Boulton AJM. Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 1989;32:724–728.

    Article  PubMed  CAS  Google Scholar 

  29. Pitei DL, Watkins PJ, Stevens MJ, Edmonds ME. The value of neurometer is assessing diabetic neuropathy by measurement of the current perception threshold. Diabetic Med 1994;11:872–876.

    Article  PubMed  CAS  Google Scholar 

  30. Veves A, Young MJ, Manes C, Boulton AJM. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: a clinical study. Diabetes Care 1994;17:1200–1203.

    Article  PubMed  CAS  Google Scholar 

  31. Vinik AI, Suwanwalaikorn S, Stansberry KB, Holland MT, McNitt PM, Colen LE. Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 1995;18:574–584.

    Article  PubMed  CAS  Google Scholar 

  32. Dyck PJ, Karnes J, O’Brian PC. Detection Thresholds of cutaneous sensation. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, eds. Diabetic Neuropathy. WB Saunders, Philadelphia, 1987, pp. 107–121.

    Google Scholar 

  33. Kimura J. Nerve conduction studies and electromyography. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral Neuropathy. Saunders, Philadelphia, 1984, pp. 919–966.

    Google Scholar 

  34. Behse F, Buchthal F. Sensory action potentials and biopsy of the sural nerve in neuropathy. Brain 1978;101:473–493.

    Article  PubMed  CAS  Google Scholar 

  35. Baba M. Diabetic nerve function: its electrophysiological evaluation. In: Ward JD, Goto Y, eds. Diabetic Neuropathy. Wiley, Chichester, UK, 1991, pp. 269–280.

    Google Scholar 

  36. Daube JR. Electrophysiologic testing in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, eds. Diabetic Neuropathy. Saunders, Philadelphia, 1987, pp. 162–176.

    Google Scholar 

  37. Daube JR. Electrophysiologic testing in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, eds. Diabetic Neuropathy. Saunders, Philadelphia, 1987, pp. 162–176.

    Google Scholar 

  38. Dyck PJ, O’Brian PC. Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy. Diabetes Care 1989;12:649–652.

    Article  PubMed  CAS  Google Scholar 

  39. Consensus Statement. 1996 Standardized measures in diabetic neuropathy. Morphological and biochemical measures. Diabetes Care 1996;19(Suppl 1):S74–S76.

    Google Scholar 

  40. Dyck PJ, Karnes JL, Daube J, O’Brien P, Service FJ. Clinical and neuropathological criteria for the diagnosis and staging of diabetic neuropathy. Brain 1985;1985:861–880.

    Article  Google Scholar 

  41. Veves A, Malik RA, Lye RH, Masson EA, Sharma AK, Schady W, Boulton AJM. Correlations between sural nerve histology and electrophysiology and quantitative sensory tests in mild diabetic neuropathy. Diabetic Med 1991;8:917–921.

    Article  PubMed  CAS  Google Scholar 

  42. Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy J O’Brien P, Service FJ. Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 1987;10:432–440.

    Article  PubMed  CAS  Google Scholar 

  43. Veves A, Young MJ, Manes C, Boulton AJM. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: a clinical study. Diabetes Care 1994;17:1200–1203.

    Article  PubMed  CAS  Google Scholar 

  44. Veves A, Manes C, Murray HJ, Young MJ, Boulton AJM. Painful neuropathy in diabetic patients with or without foot ulceration. Diabetes Care 1993;16:1187–1189.

    Article  PubMed  CAS  Google Scholar 

  45. Britland ST, Young RJ, Sharma AK, Clarke BF. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 1990;39:898–908.

    Article  PubMed  CAS  Google Scholar 

  46. Malik RA, Newrick PG, Sharma AK, Jennings A, Ah-See AK, Mayhew TM, Jakubowski J, Boulton AJM, Ward JD. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989;32:92–102.

    Article  PubMed  CAS  Google Scholar 

  47. Behse F, Buchthal F, Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977;40:1072–1082.

    Article  PubMed  CAS  Google Scholar 

  48. Ward JD, Fisher DJ, Barnes CG, Jessop JD. Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet 1971;1:428–430.

    Article  PubMed  CAS  Google Scholar 

  49. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988;11:21–32.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Veves, A. (1998). Diagnosis of Diabetic Neuropathy. In: Veves, A. (eds) Clinical Management of Diabetic Neuropathy. Contemporary Endocrinology, vol 7. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1816-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1816-6_4

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-7296-0

  • Online ISBN: 978-1-4612-1816-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics